Search results for "Psychosis"

showing 10 items of 324 documents

Differential pathophysiological mechanisms of reduced P300 amplitude in schizophrenia and depression: a single trial analysis

1997

In order to address basic mechanisms behind a reduced averaged P300 wave in schizophrenia and depression, 17 unmedicated schizophrenic and 11 unmedicated depressive subjects were tested in an 'oddball paradigm' against healthy controls matched for gender and age. The amplitude distributions of single trials' maximum positive deflections after stimulation (P300) for both target and nontarget stimuli were determined, which served as a basis for calculating the discrimination index d'. This index characterizes differences in the electrophysiological responses to target and nontarget stimuli of a subject being engaged in a discrimination task. As a main result d' was significantly lower for sch…

AdultMalePsychosismedicine.medical_specialtyAudiologyDiscrimination LearningReference ValuesReaction TimemedicineHumansAttentionPsychiatryOddball paradigmBiological PsychiatryDepression (differential diagnoses)Cerebral CortexDepressive DisorderCognitive disorderMiddle Agedmedicine.diseaseEvent-Related Potentials P300PathophysiologyPsychiatry and Mental healthElectrophysiologySchizophreniaSchizophreniaFemaleSingle trialArousalPsychologySchizophrenia Research
researchProduct

Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis

2003

Neurocognitive impairments are well documented in patients with schizophrenia and their healthy first-degree biological relatives. Less is known about neuropsychological performance in bipolar disorders, but some studies indicate that, compared to schizophrenia, bipolar disorder displays a similar profile pattern with less severe deficits. The genetic and environmental contributions to the development of neurocognitive deficits are also unclear. This study explored the effect of a family history (FH) of psychotic disorders in first-degree relatives on a variety of cognitive domains (abstraction and flexibility, verbal fluency, verbal memory, motor activity and visual-motor processing/attent…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderAdolescentNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansVerbal fluency testAttentionBipolar disorderFirst-degree relativesPsychiatryBiological PsychiatryAgedNeuropsychologyMiddle Agedmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleVerbal memoryCognition DisordersPsychologyNeurocognitiveJournal of Psychiatric Research
researchProduct

Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects.

2007

Objective:  Only a few studies have examined specifically the neuropsychological performance of schizoaffective patients. Method:  The sample consisted of 34 euthymic DSM-IV schizoaffective patients, who were compared with 41 euthymic bipolar patients without history of psychotic symptoms and 35 healthy controls. Euthymia was defined by a score of 6 or less at the Young Mania Rating Scale and a score of 8 or less at the Hamilton Depression Rating Scale for at least 6 months. Patients were compared with several clinical, occupational, and neuropsychological variables such as executive function, attention, verbal and visual memory and the two groups were contrasted with 35 healthy controls on…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderHealth StatusSchizoaffective disorderNeuropsychological TestsYoung Mania Rating ScaleSeverity of Illness IndexSurveys and QuestionnairesmedicineVerbal fluency testHumansBipolar disorderPsychiatryDemographyCognitive disorderBrainmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersFemaleVerbal memoryPsychologyCognition DisordersNeurocognitiveClinical psychologyActa psychiatrica Scandinavica
researchProduct

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

2009

To demonstrate the ability of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with adequate functioning in a sample of schizophrenic and bipolar patients, as well as in a control group.The SCIP-S, together with a full neuropsychological battery, was administered to three groups: patients with schizophrenia, patients diagnosed with bipolar disorder I, and controls. The battery scores were used to perform a standardization with respect to the control group and this served to determine the comparison groups (cognitively impaired versus unimpaired) for each of the subtests of the SCIP-S. A full analysis of decision va…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansBipolar disorderPsychiatryBiological PsychiatryCognitive deficitPsychiatric Status Rating ScalesReceiver operating characteristicCognitive disorderCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaSchizophreniaFemalemedicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologySchizophrenia Research
researchProduct

Neurodevelopmental subtypes of bipolar disorder are related to cortical folding patterns: An international multicenter study

2018

Objectives Brain sulcation is an indirect marker of neurodevelopmental processes. Studies of the cortical sulcation in bipolar disorder have yielded mixed results, probably due to high variability in clinical phenotype. We investigated whole-brain cortical sulcation in a large sample of selected patients with high neurodevelopmental load. Methods A total of 263 patients with bipolar disorder I and 320 controls were included in a multicentric magnetic resonance imaging (MRI) study. All subjects underwent high-resolution T1-weighted brain MRI. Images were processed with an automatized pipeline to extract the global sulcal index (g-SI) and the local sulcal indices (l-SIs) from 12 a priori dete…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderPrefrontal CortexPosterior parietal cortexBrain mappingArticleFunctional Laterality03 medical and health sciences0302 clinical medicineParietal LobeInternal medicinemedicineHumanspsychosisBipolar disorderPrefrontal cortexBiological PsychiatryBrain Mappingneurodevelopmentmedicine.diagnostic_testbusiness.industryBrainMagnetic resonance imagingsulcationmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryPsychiatry and Mental healthPsychotic DisordersMulticenter studyCase-Control StudiesCohortCardiologyearly-onsetFemalebusiness030217 neurology & neurosurgeryBipolar Disorders
researchProduct

Relationship between insight, violence and diagnoses in psychotic patients

2010

Abstract Introduction Lack of insight is a common clinical problem in psychiatric patients, but few times has been properly studied until recently. Patients with good insight tend to show a better treatment adherence with a better prognosis and show less hostility. This study aims to investigate whether there is a relationship between the hostility degree and insight or not and to analyse if there are insight quantitative differences between the patients regarding their diagnoses. Method One hundred and sixty-eight psychotic patients were studied (including 86 patients with schizophrenia and 43 with bipolar disorder). PANNS P7 (hostility) item and G14 (poor impulse control) were analysed in…

AdultMalePsychosismedicine.medical_specialtyBipolar Disorderbusiness.industryPsychological interventionHuman factors and ergonomicsPoison controlHostilityGeneral MedicineAwarenessViolencemedicine.diseaseSchizophreniaInjury preventionHumansMedicineFemaleSchizophrenic PsychologyBipolar disordermedicine.symptombusinessPsychiatryRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct

Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.

2018

Background: Hyperprolactinemia is a common side-effect of antipsychotics (APs), which may trigger serious secondary problems and compromise the adherence to treatment which is crucial for prognosis, especially in patients presenting with a first-episode of psychosis (FEP). Aims: We evaluated, in some cases for the first time, the effect of polymorphisms in multiple candidate genes on serum prolactin (PRL) levels in an AP-treated FEP cohort recruited in the multicenter PEPs study (Phenotype − genotype and environmental interaction; Application of a predictive model in first psychotic episodes). Methods: PRL concentration was measured in serum from 222 patients. A total of 167 polymorphisms w…

AdultMalePsychosismedicine.medical_specialtyCandidate geneSerotoninSide effectAdolescentmedicine.medical_treatmentDopaminePeptidyl-Dipeptidase A03 medical and health sciencesYoung Adult0302 clinical medicineDopaminePolymorphism (computer science)Internal medicinemedicineHumansReceptor trkBPharmacology (medical)AntipsychoticPharmacologyMembrane GlycoproteinsPolymorphism Geneticbusiness.industryReceptors Dopamine D2medicine.diseaseProlactin030227 psychiatryProlactinHyperprolactinemiaPsychiatry and Mental healthEndocrinologyPsychotic DisordersCohortFemalebusiness030217 neurology & neurosurgerymedicine.drugAntipsychotic AgentsJournal of psychopharmacology (Oxford, England)
researchProduct

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and cha…

1995

Preclinical data indicated that seroquel (ICI 204 636), a dibenzothiazepine with 5-HT2 and D2-like receptor antagonistic properties, might be an effective antipsychotic agent, causing fewer extrapyramidal side effects than typical neuroleptics. In the present study, 12 patients suffering from schizophrenia or schizophreniform disorder with predominantly positive symptomatology were treated in an open clinical trial for 4 weeks with seroquel at a maximum dosage of 750 mg/day. The drug was generally well tolerated, and virtually no adverse extrapyramidal side effects such as acute dystonia, parkinsonism or akathisia were observed. Total scores for BPRS (item score 0–6; baseline: 42.0±2.3; mea…

AdultMalePsychosismedicine.medical_specialtyDibenzothiazepinesTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticThyrotropinAkathisiaGastroenterologyQuetiapine FumarateAntipsychotic AgentInternal medicinemedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesParkinsonismElectroencephalographyMiddle Agedmedicine.diseaseProlactinTreatment OutcomeSchizophreniaAnesthesiaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyAntipsychotic AgentsPsychopharmacology
researchProduct

Differences in cannabis-related experiences between patients with a first episode of psychosis and controls

2016

BackgroundMany studies have reported that cannabis use increases the risk of a first episode of psychosis (FEP). However, only a few studies have investigated the nature of cannabis-related experiences in FEP patients, and none has examined whether these experiences are similar in FEP and general populations. The aim of this study was to explore differences in self-reported cannabis experiences between FEP and non-psychotic populations.MethodA total of 252 subjects, who met International Classification of Diseases (ICD)-10 criteria for FEP, and 217 controls who reported cannabis use were selected from the Genetics and Psychosis (GAP) study. The Medical Research Council Social Schedule and t…

AdultMalePsychosismedicine.medical_specialtyExacerbationPopulationMarijuana SmokingSociodemographic datapsychosiPsychotic Disorder03 medical and health sciencesYoung Adult0302 clinical medicineexperienceSurveys and QuestionnairesmedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansSurveys and QuestionnaireCannabiYoung adulteducationPsychiatrySettore MED/25 - PsichiatriaApplied PsychologyCannabisCannabis; Cannabis Experience Questionnaire; experiences; first episode of psychosis; psychosis; Adult; Cannabis; Female; Humans; Linear Models; Male; Marijuana Smoking; Psychiatric Status Rating Scales; Psychotic Disorders; Surveys and Questionnaires; Young Adult; Applied Psychology; Psychiatry and Mental Healthfirst episode of psychosiFirst episodePsychiatric Status Rating Scaleseducation.field_of_studybiologyCannabis usePsychiatric Status Rating Scalemedicine.diseasebiology.organism_classification030227 psychiatryPsychotic DisordersPsychiatry and Mental HealthCannabis Experience QuestionnaireLinear ModelsLinear ModelFemaleCannabisPsychology030217 neurology & neurosurgeryClinical psychologyHuman
researchProduct

Insight among psychotic patients with auditory hallucinations

2011

Poor insight in psychosis has been described as a seeming lack of awareness of the deficits, consequences of the disorder, and of the need for treatment. The aim of this study is to investigate whether patients with auditory hallucinations have less insight than those without hallucinations, and to determine which hallucination characteristics are related to patient insight. Using the PANSS and PSYRATS, the authors have evaluated the lack of insight data corresponding to 168 psychotic patients divided into three groups: patients with a history of nonpersistent hallucinations, patients with persistent hallucinations, and patients without hallucinations. Patients with persistent hallucination…

AdultMalePsychosismedicine.medical_specialtyHallucinationsComorbidityAwarenessmedicine.diseaseSeverity of Illness IndexComorbidityClinical PsychologyPsychotic DisordersArts and Humanities (miscellaneous)Interview PsychologicalSeverity of illnessmedicineHumansFemalePsychologyPsychiatryClinical psychologyJournal of Clinical Psychology
researchProduct